BioFire Defense, LLC, an affiliate of bioMérieux and leader in pathogen detection systems for the U.S. Department of Defense, was awarded the 2019 James S. Cogswell Outstanding Industrial Achievement Award from the DoD’s Defense Security Service (DSS).
SALT LAKE CITY (PRWEB) JULY 24, 2019
BioFire Defense, LLC, an affiliate of bioMérieux and leader in pathogen detection systems for the U.S. Department of Defense, was awarded the 2019 James S. Cogswell Outstanding Industrial Achievement Award from the DoD’s Defense Security Service (DSS). This award was presented to the company’s facility located in Salt Lake City, Utah, as a reflection of the sites dedication to our national security interests. BioFire Defense was selected as one of 51 recipients, from among more than 13,000 defense contractors.
To be considered for this award, BioFire Defense has established and maintained a comprehensive security program that effectively meets or exceeds National Industrial Security Program requirements. Additionally, they were required to have a minimum of two consecutive superior industrial security review ratings, which shows a sustained degree of excellence and innovation in their overall security program management, implementation, and oversight.
The James S. Cogswell Award was established in 1966 and is the most prestigious recognition by the Federal government for a cleared defense contractor that demonstrates industrial security excellence. Once initially nominated, the nominees go through a vigorous national vetting process that includes external vetting and a national team review. The national review team then consolidates and ranks the nominations, and that ranked listing is submitted to the Director of DSS for final approval.
“Credit for this accomplishment goes to Kim David, our Facility Security Officer, and her team,” said Robert Lollini, CEO of BioFire Defense. “With the support of all those whom they have trained on security, their diligence and vigilance serves to protect our national security but also our national and corporate economic interests from ever evolving internal and external threats.” Winners were announced at the 2019 Annual Conference of National Classification Management Society (NCMS), the society of industrial security professionals, in St. Louis, Missouri on June 12, 2019.
ABOUT BIOFIRE DEFENSE
BioFire Defense, LLC, formerly Idaho Technology, Inc., is a subsidiary of bioMérieux Inc. (Durham, NC) and is based in Salt Lake City, Utah. BioFire Defense is focused on technological innovation and product development of pathogen identification systems for BioThreat, public health, and industrial applications in the life sciences industry. It has developed and provided products for defense, diagnostic, food testing, and life sciences industries since 1990.
BioFire Diagnostics, LLC, its sister subsidiary, continues delivering and expanding in vitro diagnostic applications of its novel FilmArray System to hospital-based clinical laboratories across the world, offering syndromic panels which cover 5 disease areas (pneumonia, respiratory, gastro-intestinal, blood stream infections and meningitis-encephalitis).
ABOUT BIOMÉRIEUX
A world leader in the field of in vitro diagnostics for over 55 years, bioMérieux is present in 43 countries and serves more than 160 countries with the support of a large network of distributors. In 2018, revenues reached €2.4 billion, with over 90% of international sales.
bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. Its diagnostic solutions are also used for detecting microorganisms in agri-food, pharmaceutical, and cosmetic products.
bioMérieux is listed on the Euronext Paris stock market. Symbol: BIM – ISIN Code: FR0013280286
Corporate website: http://www.biomerieux.com – Investor website: http://www.biomerieux-finance.com.
